Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
02 2019
Historique:
received: 11 01 2018
revised: 04 09 2018
accepted: 22 10 2018
entrez: 29 1 2019
pubmed: 29 1 2019
medline: 7 2 2020
Statut: ppublish

Résumé

Smith-Magenis syndrome (SMS) is a contiguous gene syndrome linked to interstitial microdeletion, or mutation of RAI1, within chromosome 17p11.2. Key behavioral features of SMS include intellectual disability, sleep-disturbances, maladaptive, aggressive and self-injurious behaviors, hyperactivity, and sudden changes in mood. A distinguishing feature of this syndrome is an inverted pattern of melatonin characterized by elevated daytime and low nighttime melatonin levels. As the central circadian clock controls the 24-hr rhythm of melatonin, we hypothesized that the clock itself may contribute to the disrupted pattern of melatonin and sleep. In this report, 24-hr patterns of body temperature, a surrogate marker of clock-timing, and continuous wrist activity were collected to examine the links between body temperature, sleep behavior, and the circadian clock. In addition, age-dependent changes in sleep behavior were explored. Actigraphy-estimated sleep time for SMS was 1 hr less than expected across all ages studied. The timing of the 24-hr body temperature (Tb-24) rhythm was phase advanced, but not inverted. Compared to sibling (SIB) controls, the SMS group had less total night sleep, lower sleep efficiency, earlier sleep onset, earlier final awake times, increased waking after sleep onset (WASO), and increased daytime nap duration. The timing of wake onset varied with age, providing evidence of ongoing developmental sleep changes from childhood through adolescence. Clarification of the circadian and developmental factors that contribute to the disrupted and variable sleep patterns in this syndrome will be helpful in identifying more effective individualized treatments.

Identifiants

pubmed: 30690916
doi: 10.1002/ajmg.a.61003
pmc: PMC6699156
mid: NIHMS998830
doi:

Substances chimiques

RAI1 protein, human 0
Trans-Activators 0
Melatonin JL5DK93RCL

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-236

Subventions

Organisme : National Institutes of Health Clinical Center
Pays : International
Organisme : NIMH NIH HHS
Pays : United States
Organisme : NHGRI NIH HHS
ID : F32 HG000215
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 HG200352-01
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HG999999
Pays : United States
Organisme : Div. Intramural Research, NIMH, NIH
Pays : International
Organisme : Intramural NIH HHS
ID : Z01 HG000215
Pays : United States
Organisme : Div. Intramural Research, National Human Genome Research Institute, NIH
ID : Z1D-HG200352
Pays : International

Informations de copyright

Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Références

Sleep. 2012 Jan 01;35(1):159-66
pubmed: 22215930
Harv Rev Psychiatry. 1995 May-Jun;3(1):18-35
pubmed: 9384925
Arch Gen Psychiatry. 1998 Jan;55(1):27-32
pubmed: 9435757
Sleep. 2001 Dec 15;24(8):957-65
pubmed: 11766166
Sleep Med Rev. 2007 Dec;11(6):423-7
pubmed: 18021941
J Intellect Disabil Res. 1998 Dec;42 ( Pt 6):481-9
pubmed: 10030444
J Affect Disord. 2013 Jun;148(2-3):357-67
pubmed: 23357659
J Med Genet. 2005 Nov;42(11):820-8
pubmed: 15788730
J Clin Psychol Med Settings. 2012 Mar;19(1):77-83
pubmed: 22389163
Exp Gerontol. 2009 Jan-Feb;44(1-2):51-6
pubmed: 18579326
Am J Med Genet A. 2010 Jan;152A(1):96-101
pubmed: 20034098
Chronobiol Int. 1992;9(1):55-78
pubmed: 1555262
J Sleep Res. 2001 Jun;10(2):93-104
pubmed: 11422723
Curr Pharm Des. 2008;14(32):3396-407
pubmed: 19075716
Sleep. 2007 Jul;30(7):899-905
pubmed: 17682661
Neurosci Lett. 1991 Nov 25;133(1):36-40
pubmed: 1791996
Sleep. 2007 Nov;30(11):1445-59
pubmed: 18041479
Pediatr Neurol. 2006 May;34(5):337-50
pubmed: 16647992
Med J Aust. 2013 Oct 21;199(8):S7-10
pubmed: 24138358
J Clin Endocrinol Metab. 1991 Aug;73(2):227-35
pubmed: 1856258
Clin Genet. 2007 Jun;71(6):540-50
pubmed: 17539903
Rev Neurol (Paris). 2014 Nov;170(11):646-52
pubmed: 25287733
Brain Res Bull. 1983 May;10(5):647-52
pubmed: 6307491
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):88-91
pubmed: 16723183
Sleep. 1993 Apr;16(3):258-62
pubmed: 8506460
J Clin Endocrinol Metab. 2012 Feb;97(2):E312-8
pubmed: 22162479
PLoS One. 2014 Nov 07;9(11):e112199
pubmed: 25380248
Am J Hum Genet. 1991 Dec;49(6):1207-18
pubmed: 1746552
Sleep. 2003 May 1;26(3):342-92
pubmed: 12749557
Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):463-8
pubmed: 20981776
Sleep. 2006 Dec;29(12):1563-71
pubmed: 17252887
Chronobiol Int. 2002 May;19(3):649-58
pubmed: 12069043
Am J Med Genet. 1998 Mar 28;81(2):186-91
pubmed: 9613860
Science. 1979 Nov 9;206(4419):710-3
pubmed: 227056
Arch Gen Psychiatry. 1991 Sep;48(9):807-12
pubmed: 1929771
Expert Opin Ther Targets. 2016 Oct;20(10):1209-18
pubmed: 27082492
Sleep Med. 2001 Sep;2(5):389-96
pubmed: 14592388
Nat Sci Sleep. 2013 Jul 22;5:93-107
pubmed: 23901303
Psychopharmacol Bull. 1984 Summer;20(3):561-5
pubmed: 6473662
Arch Gen Psychiatry. 2001 Dec;58(12):1108-14
pubmed: 11735838
Am J Med Genet. 1996 Mar 29;62(3):247-54
pubmed: 8882782
Dev Med Child Neurol. 1997 Jun;39(6):414-8
pubmed: 9233368
J Dev Behav Pediatr. 2015 Apr;36(3):166-77
pubmed: 25741949
J Pediatr. 2001 Jul;139(1):111-6
pubmed: 11445803
Genet Med. 2006 Jul;8(7):417-27
pubmed: 16845274
Dialogues Clin Neurosci. 2012 Dec;14(4):335-7
pubmed: 23393412
Neurosci Lett. 1995 Dec 1;201(1):13-6
pubmed: 8830301
Sleep Med Rev. 2014 Feb;18(1):75-87
pubmed: 23806891
Chronobiol Int. 1989;6(1):93-102
pubmed: 2706705
Hum Neurobiol. 1982;1(3):173-83
pubmed: 6764464
Phys Occup Ther Pediatr. 2012 Feb;32(1):48-65
pubmed: 21599572
Am J Med Genet A. 2009 Jul;149A(7):1382-91
pubmed: 19530184
Am J Med Genet. 1998 Mar 28;81(2):179-85
pubmed: 9613859
Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):456-62
pubmed: 20981775
Sleep Med. 2013 Apr;14(4):319-23
pubmed: 23419528
Chronobiol Int. 1992 Oct;9(5):380-92
pubmed: 1394610
J Med Genet. 2000 Jun;37(6):428-33
pubmed: 10851253
J Physiol. 2012 Jul 1;590(13):3035-45
pubmed: 22547633
J Med Genet. 2003 Jan;40(1):74-8
pubmed: 12525548
Am J Hum Genet. 2012 Jun 8;90(6):941-9
pubmed: 22578325
J Neural Transm Suppl. 1986;21:311-22
pubmed: 3462337
Curr Neurol Neurosci Rep. 2008 Mar;8(2):155-61
pubmed: 18460285
N Engl J Med. 2000 Oct 12;343(15):1070-7
pubmed: 11027741

Auteurs

Ann C M Smith (ACM)

Office of the Clinical Director, Division of Intramural Research at the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Rebecca S Morse (RS)

Office of the Clinical Director, Division of Intramural Research at the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Wendy Introne (W)

Office of the Clinical Director, Division of Intramural Research at the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Wallace C Duncan (WC)

Division of Intramural Research at the National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH